Cargando…
Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators
The COVID-19 pandemic has affected more than 10 million people worldwide with mortality exceeding half a million patients. Risk factors associated with severe disease and mortality include advanced age, hypertension, diabetes, and obesity.(1) Clear mechanistic understanding of how these comorbiditie...
Autores principales: | Schwarz, Benjamin, Sharma, Lokesh, Roberts, Lydia, Peng, Xiaohua, Bermejo, Santos, Leighton, Ian, Massana, Arnau Casanovas, Farhadian, Shelli, Ko, Albert I., Cruz, Charles S. Dela, Bosio, Catharine M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386513/ https://www.ncbi.nlm.nih.gov/pubmed/32743565 http://dx.doi.org/10.21203/rs.3.rs-42999/v1 |
Ejemplares similares
-
Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators
por: Schwarz, Benjamin, et al.
Publicado: (2020) -
Pulmonary infection induces persistent, pathogen-specific lipidomic changes influencing trained immunity
por: Roberts, Lydia M., et al.
Publicado: (2021) -
Targeted Lipidomics for Characterization of PUFAs and Eicosanoids in Extracellular Vesicles
por: Reinicke, Madlen, et al.
Publicado: (2022) -
A targeted lipidomics approach to the study of eicosanoid release in synovial joints
por: de Grauw, Janny C, et al.
Publicado: (2011) -
Pooling saliva to increase SARS-CoV-2 testing capacity
por: Watkins, Anne E., et al.
Publicado: (2020)